내가 좋아할 만한 콘텐츠
News! @modal_labs is supporting @RAAIS fellowships with $10,000 credits on their platform, alongside the $5,000 GPU credits from @LambdaAPI. Working on AI-first, open source research outside big institutions? Apply at airstreet(dot)com/fellowships
News! We’re delighted to announce that applications are open for a new batch of @RAAIS fellowships - provided support to AI-first, open source research outside big institutions. Apply at airstreet(dot)com/fellowships Many thanks to our partners @LambdaAPI for their support.
Thank you to our friends over at @decodingbio for featuring PRISM, our foundation model for life's chemistry, in their latest newsletter. To check out the excellent Decoding Bio newsletter: decodingbio.substack.com/p/biobyte-078-…
Mass spectrometry people, if you're at #ASMS this year, come see my talk at the Bruker eXceed symposium Multiomics breakout session Sunday at 12 noon, I'll be talking about our new PRISM foundation model.
Working on ML for Drug Discovery I have been frustrated with the size and/or quality of publicly available datasets to train and benchmark models with, so when my co-founder and I started our company we swore we would open-source some data as quickly as possible.
In a new post with @NaefLuca @vant_ai we ask what is needed for ML to succeed in biological problems and argue that it is necessary to move beyond "white-box data" michael-bronstein.medium.com/the-road-to-bi… w inputs from @nathanbenaich @dom_beaini @befcorr @georg_e_winter @schwabpa @ggrigoryanv
🪩The @stateofaireport 2023 is now here. Our 6th installment is one of the most exciting years I can remember. The #stateofai report covers everything you *need* to know, covering research, industry, safety and politics. There’s lots in there, so here’s my director’s cut 🧵
We’re grateful to @ClarivateHealth for recognizing us as a leader in using innovative #AI #ML technologies to upend the drug discovery and development paradigm in their annual “Companies to Watch” report! clarivate.com/lp/companies-t…
We are proud to be selected by the @endpts editorial team as one of the most promising and ambitious #biotech startups! We’re grateful for the recognition of what we’ve built so far and where we are headed next: the clinic in 2024! endpts.com/the-endpoints-…
MS2Mol preprint is out! De novo structure prediction of molecules from mass spectra!
📰Pre-print alert!📰 It is with great pride and excitement that we share the details of our latest AI model, MS2Mol, to unlock nature’s chemical code. Read on to learn more about the tech and how we use it to translate the language of chemistry 🧵👇 /1
We're excited to announce our Series B1, which brings the total round to US $119 M. Led by @KinnevikAB with outsized support of existing investors, the funding will continue to fuel platform growth and progress multiple platform-derived molecules to the clinic in 2023-24 🚀…
If you're trying to figure out what nature's chemistry looks like, you'll want to be able to predict the mass spectra of molecules. Check out this blog on our work at @envedabio using graph neural networks to get better and more scalable predictions!
@EnvedaBio, we're building advanced #ML models to learn the language of nature’s chemistry. Today on the blog, @mixterhealey & team describe our latest model, GRAFF-MS, and its elegant solution to a common obstacle to applying ML in #metabolomics: bit.ly/3IJ9yvY.
Congrats to @BiswapriyaMisra, whose paper was selected the best review article of 2021 in @Metabolomics. A key step in transforming a field is knowing it very well (more on that soon!). We celebrate with you & are more proud to call you colleague & friend! bit.ly/3KebDh8
1/ @envedabio is building the largest integrated anthropological, biological, and chemical knowledge graph (KG) of the natural world to drive a new era of rational drug discovery. Check out the thread below! 🧵
A well-deserved milestone for @RecursionChris and the whole team at @RecursionPharma! In building up @envedabio I feel fortunate every day to have been part of the world class team at Recursion and to have learned from the best. Best of luck, Recursionauts!
I’m excited about the next stage of growth for @RecursionPharma as we become a public company - $RXRX! Our team has worked tirelessly to achieve this milestone and now it is time to put our heads down and get back to work on our mission! Thanks to all who have supported us!
I joined @envedabio because I think spectral interpretation and metabolomics is the best opportunity to revolutionize drug discovery with ML that I've ever seen. #metabolomics #AI #drugdiscovery #naturalproducts Here's a blog: lnkd.in/eTh-xpR
me: what’s your name? alien: it cannot be pronounced by your earth tongue me: is it jeff? alien: me: alien: I didn’t know you could do j sounds it actua—it is jeff
Germany, by two Turkish immigrants.
That’s great. Just out of curiosity, which country was it that developed the vaccine? Wonder why.
United States 트렌드
- 1. Staged N/A
- 2. #WonderMan N/A
- 3. Musetti N/A
- 4. Djokovic N/A
- 5. Ilhan Omar N/A
- 6. Dort N/A
- 7. Belichick N/A
- 8. Jamal Murray N/A
- 9. Purdue N/A
- 10. #iubb N/A
- 11. Fears N/A
- 12. J Cole N/A
- 13. Jussie Smollett N/A
- 14. Kendrick N/A
- 15. Pond N/A
- 16. Nebraska N/A
- 17. Pope N/A
- 18. Hall of Fame N/A
- 19. Bill Polian N/A
- 20. Michigan N/A
내가 좋아할 만한 콘텐츠
-
Viswa Colluru
@viswacolluru -
Enveda
@lifeschemistry -
AtaiBeckley Inc
@ataibeckley -
Hannah Gordon PhD, MSCI (she/her)
@brieski -
Nicolas Tilmans
@ntilmans -
Solvonis Therapeutics plc
@Solvonis -
Imran S. Haque (@ihaque@{bsky,genomic}.social)
@ImranSHaque -
August Allen
@augallen -
The Tugizimana Lab
@FT_ResearchUJ -
Chase Neumann
@OncNTechStuff -
andrew blevins
@Andrewdblevins
Something went wrong.
Something went wrong.